Author： Hersh Craig P
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.11, Iss.2, 2010-02, pp. : 237-247
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Pharmacogenetics of chronic obstructive pulmonary disease
Pharmacogenomics, Vol. 14, Iss. 10, 2013-07 ,pp. :
Access to resources
Recommend
Chronic obstructive pulmonary disease: new opportunities for drug development
By Barnes P.J.
Trends in Pharmacological Sciences, Vol. 19, Iss. 10, 1998-10 ,pp. :
Indacaterol: In Chronic Obstructive Pulmonary Disease
Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. :
Roflumilast: In Chronic Obstructive Pulmonary Disease
By Sanford Mark
Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. :
Aclidinium: In Chronic Obstructive Pulmonary Disease
Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. :